DE69915327D1 - Derivate des erythromycins, des clarithromycins, des roxithromycins oder des azithromycin mit antibiotischer und mucolytischer wirkung - Google Patents

Derivate des erythromycins, des clarithromycins, des roxithromycins oder des azithromycin mit antibiotischer und mucolytischer wirkung

Info

Publication number
DE69915327D1
DE69915327D1 DE69915327T DE69915327T DE69915327D1 DE 69915327 D1 DE69915327 D1 DE 69915327D1 DE 69915327 T DE69915327 T DE 69915327T DE 69915327 T DE69915327 T DE 69915327T DE 69915327 D1 DE69915327 D1 DE 69915327D1
Authority
DE
Germany
Prior art keywords
antibiotic
mucolytic
roxithromycin
clarithromycin
azithromycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69915327T
Other languages
English (en)
Other versions
DE69915327T2 (de
Inventor
Helmut Schickaneder
Aggelos Nikolopoulos
Gesine Hermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Russinsky Ltd
Original Assignee
Russinsky Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Russinsky Ltd filed Critical Russinsky Ltd
Publication of DE69915327D1 publication Critical patent/DE69915327D1/de
Application granted granted Critical
Publication of DE69915327T2 publication Critical patent/DE69915327T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE69915327T 1998-10-20 1999-10-15 Derivate des erythromycins, des clarithromycins, des roxithromycins oder des azithromycin mit antibiotischer und mucolytischer wirkung Expired - Fee Related DE69915327T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IE980869 1998-10-20
IE980869 1998-10-20
IE981062 1998-12-17
IE981062 1998-12-17
PCT/IE1999/000106 WO2000023081A1 (en) 1998-10-20 1999-10-15 Derivatives of erythromycin, clarithromycin, roxithromycin or azithromycin with antibiotic and mucolytic activity

Publications (2)

Publication Number Publication Date
DE69915327D1 true DE69915327D1 (de) 2004-04-08
DE69915327T2 DE69915327T2 (de) 2005-02-10

Family

ID=26320218

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69915327T Expired - Fee Related DE69915327T2 (de) 1998-10-20 1999-10-15 Derivate des erythromycins, des clarithromycins, des roxithromycins oder des azithromycin mit antibiotischer und mucolytischer wirkung

Country Status (7)

Country Link
US (1) US6599885B2 (de)
EP (1) EP1121134B1 (de)
AT (1) ATE260665T1 (de)
AU (1) AU760884B2 (de)
CA (1) CA2346870A1 (de)
DE (1) DE69915327T2 (de)
WO (1) WO2000023081A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0109544A (pt) * 2000-03-28 2003-06-10 Biochemie Gmbh Partìculas granuladas com sabor ocultado
WO2007008537A2 (en) * 2005-07-07 2007-01-18 Elan Pharma International, Limited Nanoparticulate clarithromycin formulations
WO2010014306A1 (en) * 2008-07-28 2010-02-04 Tyco Healthcare Group Lp Antimicrobial and anticoagulant compositions and methods
BR112012014926A2 (pt) * 2009-12-18 2015-09-15 Univ Northwest composição compreendendo uma forma vítrea não cristalina e amorfa de azitromicina
CN104177457A (zh) * 2013-05-23 2014-12-03 长春海悦药业有限公司 一种阿奇霉素药物原料及其制剂和用途
MX2020000265A (es) 2017-07-07 2020-07-22 Epicentrx Inc Composiciones para la administración parenteral de agentes terapéuticos.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2824443A1 (de) 1978-06-03 1979-12-13 Basf Ag Lagerstabile und fliessfaehige silikatsuspensionen
IT1134457B (it) * 1980-11-26 1986-08-13 Real Sas Di Alberto Reiner Derivato dell'alfa-mercapto propionilglicina ad attivita' terapeutica,procedimento per la sua preparazione e relative composizioni farmaceutiche
IT1134458B (it) * 1980-11-26 1986-08-13 Real Sas Di Alberto Reiner Derivato della n-acetil-cisteina ad attivita' terapeutica,procedimento per la sua preparazione e relative composizioni farmaceutiche
FR2519988B1 (fr) * 1982-01-20 1985-06-14 Refarmed Sa Derives thioliques de l'erythromycine a activite therapeutique, procede de preparation et produits pharmaceutiques dans lesquels ils apparaissent
FR2502627A1 (fr) 1981-02-02 1982-10-01 Refarmed Sa Derives thioliques de l'erythromycine a activite therapeutique, procede de preparation et produits pharmaceutiques dans lesquels ils apparaissent
IT1189285B (it) * 1982-05-28 1988-02-04 Nuovo Consor Sanitar Nazionale Sali dell'antibiotico eritromicina e del suo estere propionico con acidi ad attivita' terapeutica coadiuvante
WO1996019489A1 (en) * 1994-12-19 1996-06-27 Russinsky Limited Compounds
CA2255124A1 (en) * 1996-08-07 1998-02-12 Helmut Schickaneder A process for the production of pharmaceuticals

Also Published As

Publication number Publication date
EP1121134A1 (de) 2001-08-08
AU6118599A (en) 2000-05-08
US6599885B2 (en) 2003-07-29
WO2000023081A1 (en) 2000-04-27
US20010031736A1 (en) 2001-10-18
ATE260665T1 (de) 2004-03-15
DE69915327T2 (de) 2005-02-10
EP1121134B1 (de) 2004-03-03
CA2346870A1 (en) 2000-04-27
AU760884B2 (en) 2003-05-22

Similar Documents

Publication Publication Date Title
IL166527A0 (en) Macrolide compounds endowed with antiinflammatory activity
WO2003004509A3 (en) C12 modified erythromycin macrolides and ketolides having antibacterial activity
BR9502016A (pt) Derivado de propiofenona processo para a preparação do mesmo composição farmacêutica agente antidiabete e uso do dito derivado
AU2002239841A1 (en) Proteoglycan compositions for treatment of inflammatory conditions
NZ335825A (en) Use of azithromycin for treating atherosclerosis
NO20050893L (no) 13-leddete azalider og deres anvendelse som antibiotiske midler
EA200000594A1 (ru) Новые макролиды
NO2011002I2 (no) Regadenoson og salter derav
DE69915327D1 (de) Derivate des erythromycins, des clarithromycins, des roxithromycins oder des azithromycin mit antibiotischer und mucolytischer wirkung
HUP0004579A2 (hu) Antibakteriális hatású, a 3'-N-pozícióban módosított szerkezetű 6-0-szubsztituált-eritromicin-ketolid-származékok és ezeket tartalmazó gyógyszerkészítmények
DK1216256T3 (da) Makrolid-antibiotika og behandling af pasteurellosis
DE60303967D1 (de) 9a-azalide mit entzündungshemmender wirkung
NO20012272L (no) Nye erythromycinderivater, fremstillingsmetode og anvendelse som medisiner
DK1004592T3 (da) Nye erythromycinderivater, deres fremstilling og deres anvendelse som medikamenter
IS2258B (is) Setin tríasóló-pýridasín afleiða, lyfjasamsetningar gerðar úr henni
AU5290199A (en) Erythromycin derivatives with antibiotic activity
HK1064607A1 (en) Use of sucralfate for the preparation of medicament of cervical erosion treatment
BR0317539A (pt) Métodos e composições para o tratamento de infecções por vìrus da herpes usando inibidores seletivos da ou ciclooxigenase-2 ou inibidores da ciclooxigenase-2 em combinação com agentes antivirais
DE69923835D1 (de) Makrolid-lhrh-antagonisten
BR0207061A (pt) Composição e método para o tratamento de lúpus e de doenças inflamatórias das articulações
BR0008890A (pt) Método de redução da incidência da doença ascite em aves
AR011105A1 (es) Formulacion de liposoma parenteral que reduce el dolor
NO950143L (no) Derivater av antibiotiske makrolider med 16-leddet ring
FI20011446A (fi) Farmaseuttinen, brivudiinia sisältävä, kerran päivässä käytettävä koostumus
Hlasta et al. Ketolide antibacterials

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee